Short sellers in Moderna (MRNA +7.7%) are wondering where the peak is in the messenger RNA (mRNA) therapeutics developer. Shares have rallied 44% since April 2. According to FINRA, short interest has jumped over 22% to 11.44M shares.
Fellow mRNA player Translate Bio (TBIO +4.8%) is up as well, albeit on below-average volume.
Subscribe for full text news in your inbox